Amcor plc
Congress has disclosed 9 buys and 6 sells of AMCR (Amcor plc) in official financial disclosures, each linked to its original filing. A transparency record — not investment advice.
Activity Congressional Activity
Round-trip watch Still on the books
Members who disclosed buying AMCR and have not disclosed selling, versus their own entry (the most recent disclosed buy). "Open" means no disclosed sale — never "still holds" — and the % is unrealised, on paper. Not investment advice.
| Member | Entry (last buy) | Entry price | Now | vs entry | Status |
|---|---|---|---|---|---|
| Rohit Khanna | 2026-05-01 | $36.61 | $47.39 | +29.5% | in profit |
| Thomas Kean | 2026-05-14 | $37.42 | $47.39 | +26.6% | in profit |
| Alan Armstrong | 2026-03-27 | $37.45 | $47.39 | +26.5% | in profit |
| Dan Newhouse | 2026-07-10 | $42.57 | $47.39 | +11.3% | in profit |
Price as of 2026-10-30. Counted open while disclosed buys outnumber disclosed sells; tracks the price, not exact position size (amounts are ranges).
Fundamentals · FY2026 Valuation
Standard valuation multiples from SEC-reported GAAP financials (trailing twelve months), each compared to the median for Industrials. We use reported GAAP, not forward or adjusted earnings, so our figures can sit higher than sites that do — especially for companies with falling profit. Relative context — not a target price or investment advice.
how it's calculated
how it's calculated
how it's calculated
16 trades Recent Congressional Trades
Two things to watch per trade: the disclosure lag (how many days passed before the trade was made public) and the price move in that window (how the stock moved during those non-public days). A sell followed by a price drop, or a buy followed by a rise, means well-timed trading — visible here in the open. Note: the Score measures how notable a trade is, not whether it made money — the price move is shown for context and isn't part of it.
| Politician | Chamber | Type | Owner | Date | Disclosure lag | Price move in that window | Amount | Score | Source |
|---|---|---|---|---|---|---|---|---|---|
| Thomas Kean | House | SELL | Self · Kean Family Partnership | 2026-08-10 | 22 days | -2.7% | $1K–$15K 0.1% of NW |
32.3 | ↗ filing |
| Dan Newhouse | House | BUY | Spouse · Edward Jones IRA | 2026-07-10 | 0 days | 0.0% | $1K–$15K <0.1% of NW |
69.7 | ↗ filing |
| Thomas Kean | House | BUY | Self · Kean Family Partnership | 2026-05-14 | 19 days | +1.2% | $1K–$15K 0.1% of NW |
29.7 | ↗ filing |
| Rohit Khanna | House | BUY OCR | Child | 2026-05-01 | 38 days | +1.9% | $1K–$15K | 92.1 | ↗ filing |
| Thomas Kean | House | BUY | Self · Kean Family Partnership | 2026-03-31 | 3 days | +0.5% | $1K–$15K 0.1% of NW |
47.6 | ↗ filing |
| Alan Armstrong | Senate | BUY | Self | 2026-03-27 | 116 days | +14.4% | $1K–$15K | 89.2 | ↗ eFD |
| Gilbert Cisneros | House | SELL ◆ insider divergence · strong | Self · 150 Main Street Trust > Bank of America | 2025-12-19 | 21 days | +4.3% | $1K–$15K 0.1% of NW |
28.3 | ↗ filing |
| Gilbert Cisneros | House | BUY ◆ insider convergence · strong | Self · 150 Main Street Trust > Bank of America | 2025-11-18 | 24 days | -1.2% | $1K–$15K 0.1% of NW |
64.0 | ↗ filing |
| Thomas Kean | House | BUY ◆ insider convergence · moderate | Self · Kean Family Partnership | 2025-08-15 | 18 days | -3.6% | $1K–$15K 0.1% of NW |
63.0 | ↗ filing |
| Rob Bresnahan | House | BUY | Self · JP Morgan Brokerage Account | 2025-05-15 | 0 days | 0.0% | $1K–$15K 0.2% of NW |
28.5 | ↗ filing |
| Ron Wyden | Senate | EXCHANGE | Spouse | 2025-04-30 | 465 days | +12.1% | $100K–$250K | 99.9 | ↗ eFD |
| Rob Bresnahan | House | SELL ◆ insider divergence · strong | Self · JP Morgan Brokerage Account | 2025-04-08 | 0 days | 0.0% | $1K–$15K 0.2% of NW |
64.4 | ↗ filing |
| Daniel Goldman | House | SELL ◆ insider convergence | Self · Daniel Goldman Grandchildren 1986 Trust > TACS R3K | 2023-07-12 | 27 days | — | $1K–$15K <0.1% of NW |
75.9 | ↗ filing |
| Kathy Manning | House | SELL | Joint · Charles Schwab - O'Shaughnessy Asset Management | 2022-08-03 | 34 days | — | $1K–$15K 0.1% of NW |
40.5 | ↗ filing |
| Kathy Manning | House | BUY | Joint · Charles Schwab - O'Shaughnessy Asset Management | 2022-07-20 | 13 days | — | $1K–$15K 0.1% of NW |
75.9 | ↗ filing |
| John Rutherford | House | SELL | Self | 2022-02-17 | 0 days | — | $1K–$15K 0.8% of NW |
75.9 | ↗ filing |
Corporate insiders · SEC Form 4 Insider Activity
What the company's own officers and directors did in AMCR — open-market purchases and sales from SEC Form 4 filings (option exercises, grants and tax withholding are excluded). This is context for the congressional activity above, never a buy/sell signal, and the two datasets are kept separate on purpose. Does convergence mean anything? →
Of the congressional trades in AMCR, 3 coincided with corporate insiders moving the same way within 60 days, and 2 with insiders moving the opposite way. This is co-occurrence only — whether it carries any edge is tested honestly on the convergence page.
| Date | Insider | Role | Type | Size | Source |
|---|---|---|---|---|---|
| 2025-12-11 | Scherger Stephen R. | C-suite | BUY | $1.0M | ↗ EDGAR |
| 2025-12-03 | CARTER SUSAN K | Director | SELL | $51K | ↗ EDGAR |
| 2025-12-03 | Rahman Jill A | Director | SELL | $35K | ↗ EDGAR |
| 2025-11-24 | Rahman Jill A | Director | SELL | $56K | ↗ EDGAR |
| 2025-11-12 | Long Nicholas T. | Director | BUY | $85K | ↗ EDGAR |
| 2025-11-10 | Konieczny Peter | C-suite | BUY | $505K | ↗ EDGAR |
| 2025-11-10 | Wilson Ian | Other | BUY | $660K | ↗ EDGAR |
| 2025-11-10 | Glerum James T Jr. | Director | BUY | $1K | ↗ EDGAR |
| 2025-11-10 | Glerum James T Jr. | Director | BUY | $499K | ↗ EDGAR |
| 2025-08-19 | STERRETT STEPHEN E | Director | BUY | $86K | ↗ EDGAR |
| 2025-03-03 | Foufopoulos - De Ridder Lucrece | Director | BUY | $144K | ↗ EDGAR |
| 2025-02-27 | Agarwal Achal | Director | BUY | $101K | ↗ EDGAR |
| 2025-02-19 | Agarwal Achal | Director | BUY | $101K | ↗ EDGAR |
| 2025-02-19 | Agarwal Achal | Director | BUY | $101K | ↗ EDGAR |
| 2025-02-18 | Agarwal Achal | Director | BUY | $101K | ↗ EDGAR |
| 2025-02-18 | Agarwal Achal | Director | BUY | $101K | ↗ EDGAR |
| 2025-02-12 | NAYAR ARUN | Director | BUY | $587K | ↗ EDGAR |
| 2025-02-12 | NAYAR ARUN | Director | BUY | $328K | ↗ EDGAR |
| 2025-02-12 | NAYAR ARUN | Director | BUY | $80K | ↗ EDGAR |
| 2025-02-10 | Konieczny Peter | C-suite | BUY | $1.0M | ↗ EDGAR |
| 2024-12-03 | Long Nicholas T. | Director | SELL | $76K | ↗ EDGAR |
| 2024-12-03 | Bertone Andrea E. | Director | SELL | $65K | ↗ EDGAR |
| 2024-09-03 | SORRELLS JULIE MARIE | Other | SELL | $91K | ↗ EDGAR |
| 2024-02-09 | Roegner Eric V | C-suite | BUY | $5K | ↗ EDGAR |
| 2024-02-09 | Roegner Eric V | C-suite | BUY | $5K | ↗ EDGAR |
Combined timeline — Congress & insiders
Both sets of trades on one timeline, newest first, so you can see when they lined up. Congress vs ◆ insider.
| Date | Who | Type | Size | |
|---|---|---|---|---|
| Congress | 2026-08-10 | Thomas Kean | SELL | $1K–$15K |
| Congress | 2026-07-10 | Dan Newhouse | BUY | $1K–$15K |
| Congress | 2026-05-14 | Thomas Kean | BUY | $1K–$15K |
| Congress | 2026-05-01 | Rohit Khanna | BUY | $1K–$15K |
| Congress | 2026-03-31 | Thomas Kean | BUY | $1K–$15K |
| Congress | 2026-03-27 | Alan Armstrong | BUY | $1K–$15K |
| Congress | 2025-12-19 | Gilbert Cisneros | SELL | $1K–$15K |
| ◆ insider | 2025-12-11 | Scherger Stephen R. C-suite | BUY | $1.0M |
| ◆ insider | 2025-12-03 | CARTER SUSAN K Director | SELL | $51K |
| ◆ insider | 2025-12-03 | Rahman Jill A Director | SELL | $35K |
| ◆ insider | 2025-11-24 | Rahman Jill A Director | SELL | $56K |
| Congress | 2025-11-18 | Gilbert Cisneros | BUY | $1K–$15K |
| ◆ insider | 2025-11-12 | Long Nicholas T. Director | BUY | $85K |
| ◆ insider | 2025-11-10 | Konieczny Peter C-suite | BUY | $505K |
| ◆ insider | 2025-11-10 | Wilson Ian Other | BUY | $660K |
| ◆ insider | 2025-11-10 | Glerum James T Jr. Director | BUY | $1K |
| ◆ insider | 2025-11-10 | Glerum James T Jr. Director | BUY | $499K |
| ◆ insider | 2025-08-19 | STERRETT STEPHEN E Director | BUY | $86K |
| Congress | 2025-08-15 | Thomas Kean | BUY | $1K–$15K |
| Congress | 2025-05-15 | Rob Bresnahan | BUY | $1K–$15K |
| Congress | 2025-04-30 | Ron Wyden | EXCHANGE | $100K–$250K |
| Congress | 2025-04-08 | Rob Bresnahan | SELL | $1K–$15K |
| ◆ insider | 2025-03-03 | Foufopoulos - De Ridder Lucrece Director | BUY | $144K |
| ◆ insider | 2025-02-27 | Agarwal Achal Director | BUY | $101K |
FAQ Common questions
How much has Congress traded AMCR?
9 disclosed buys and 6 sells of AMCR (Amcor plc) appear in official congressional financial disclosures.
Is it legal for members of Congress to trade AMCR?
Members of Congress may trade stocks but must disclose it under the STOCK Act. QuantCapitol tracks those public disclosures for transparency — nothing here is an accusation of wrongdoing or investment advice.
Where does this data come from?
Official US House Clerk and Senate electronic financial disclosures. Every trade links back to its original filing so you can verify it yourself.